MRK - New COVID-19 Vaccine Mandates Make Rapid COVID Tests More Essential Than Ever

With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated,  rapid COVID tests and treatments are more important than ever. Perhaps even more alarming is the fact that the Centers for Disease Control and Prevention (CDC) attributes between 80% and 87% of all US COVID-19 cases in the last two weeks of July to the new Delta variant. As biotechnology companies like Cocrystal Pharma Inc. (NASDAQ:COCP) and Merck & Co. (NYSE:MRK) continue working to create antiviral treatments for COVID-19 and emerging variants and ...